Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of anti-diabetic agents
Although several treatment options are available to reduce hyperglycemia, only about half of individuals with diagnosed diabetes mellitus (DM) achieve recommended glycemic targets. New agents that reduce blood glucose concentrations by novel mechanisms and have acceptable safety profiles are needed...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2014-12-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | http://www.drugsincontext.com/sodium-glucose-co-transporter-2-sglt2-inhibitors-growing-class-anti-diabetic-agents/ |